What we are working on

Our scientists take a rigorous, comprehensive approach to understanding cancer biology and drug discovery.

With one of the strongest pipelines in the industry, Roche Neuroscience is developing medicines for a range of serious neurological diseases, including multiple sclerosis, Alzheimer’s disease, autism, spinal muscular atrophy, depression, Parkinson’s disease, Down syndrome.

Viral and bacterial infections are among the leading causes of disability and death. Roche research is committed to finding effective treatments for life-threatening infectious diseases.

We're advancing our expertise in Immunology and discovering and developing innovative medicines for patients living with severe respiratory and autoimmune diseases.

Our medical innovations treat cardiovascular and metabolism diseases such as heart attacks and diabetes.

We assess emerging technologies and quickly adopt the ones that can enhance our research efforts in finding new drugs and better diagnostic tests.

We are working on addressing the leading causes of blindness.

Haematology is a branch of medicine that deals with diseases of the blood. It is a complex, disparate and challenging area of medicine.

Haemophilia A is an inherited bleeding disorder where a person’s blood does not clot properly, leading in severe cases to uncontrolled bleeding, either spontaneously or after minor trauma.

Working in both Pharmaceuticals and Diagnostics, we are uniquely positioned to fit the treatment to the patients.

Roche Respiratory research focuses on severe respiratory diseases.